Martin Denzel
Principal Investigator at AltosLabs and researcher at Max Planck Institute for Biology of Ageing
Martin went to Marburg University for his training as a Human Biologist. He obtained his Ph.D. from Sanford-Burnham Medical Research Institute in La Jolla, CA. In Barbara Ranscht's lab, he studied the interaction of the cytokine adiponectin with its receptor T-cadherin in the context of angiogenesis and heart disease. Then he went on to do his PostDoc with Adam Antebi at the Max Planck Institute for Biology of Ageing in Cologne. This is where he first used the nematode C. elegans for genetic screens.
Visit website: https://altoslabs.com/team/principal-investigators-cambridge/martin-denzel/
See also: 
Altos Labs
- Biotechnology company focused on cellular rejuvenation programming
Details last updated 11-Feb-2022
Martin Denzel is also referenced in the following:
Mutagenesis screens define conserved functions of metabolism and longevity
28-Feb-2022
Online event by OSAL where Martin Denzel speaks on the role of protein homeostasis in health and longevity (FREE)
Nutrition and the biology of ageing
12-Sep-2022 to 14-Sep-2022
Event about nutrition and its impact on metabolism organized by British Society for Research on Ageing
